Massachusetts General Hospital Dept of Cancer for Melanoma — Boston, Massachusetts

Massachusetts General Hospital Dept of Cancer for Melanoma is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Massachusetts General Hospital Dept of Cancer for Melanoma has participated in 1 clinical trials.

Therapeutic areas: Metastatic Melanoma.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusetts General Hospital Dept of Cancer for Melanoma?

Massachusetts General Hospital Dept of Cancer for Melanoma has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusetts General Hospital Dept of Cancer for Melanoma conducted?

Massachusetts General Hospital Dept of Cancer for Melanoma has 1 clinical trials on record. Their work covers Metastatic Melanoma.

Is Massachusetts General Hospital Dept of Cancer for Melanoma accredited by Crixeo Health?

Massachusetts General Hospital Dept of Cancer for Melanoma has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Massachusetts General Hospital Dept of Cancer for Melanoma?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.